SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004288
Filing Date
2019-03-29
Accepted
2019-03-29 17:19:31
Documents
60
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 989054
2 ex31-1.htm EX-31.1 19874
3 ex31-2.htm EX-31.2 20229
4 ex32.htm EX-32 11453
5 ex99-1.htm EX-99.1 15738
  Complete submission text file 0001493152-19-004288.txt   3891444

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ptix-20181231.xml EX-101.INS 585244
7 XBRL SCHEMA FILE ptix-20181231.xsd EX-101.SCH 42785
8 XBRL CALCULATION FILE ptix-20181231_cal.xml EX-101.CAL 46098
9 XBRL DEFINITION FILE ptix-20181231_def.xml EX-101.DEF 179786
10 XBRL LABEL FILE ptix-20181231_lab.xml EX-101.LAB 310974
11 XBRL PRESENTATION FILE ptix-20181231_pre.xml EX-101.PRE 256725
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51353 | Film No.: 19717726
SIC: 7389 Services-Business Services, NEC